Medtronic (NYSE:MDT) CEO Omar Ishrak said yesterday that the medical device titan is planning to use the billions in foreign cash it gained access to when it acquired Covidien to buy up early-stage technologies and add them to its product pipeline. Fridley, Minn.-based Medtronic paid $50 billion for Covidien in January, allowing it to re-incorporate in […]
The post Medtronic CEO: We’re looking at early-stage acquisitions appeared first on MassDevice.
from MassDevice http://ift.tt/1ePpyvB
Cap comentari:
Publica un comentari a l'entrada